370 related articles for article (PubMed ID: 30514297)
1. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
[TBL] [Abstract][Full Text] [Related]
2. SOX30 is a key regulator of desmosomal gene suppressing tumor growth and metastasis in lung adenocarcinoma.
Hao X; Han F; Ma B; Zhang N; Chen H; Jiang X; Yin L; Liu W; Ao L; Cao J; Liu J
J Exp Clin Cancer Res; 2018 May; 37(1):111. PubMed ID: 29855376
[TBL] [Abstract][Full Text] [Related]
3. High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma.
Han F; Liu W; Xiao H; Dong Y; Sun L; Mao C; Yin L; Jiang X; Ao L; Cui Z; Cao J; Liu J
Sci Rep; 2015 Sep; 5():13630. PubMed ID: 26330328
[TBL] [Abstract][Full Text] [Related]
4. SOX30 Inhibits Tumor Metastasis through Attenuating Wnt-Signaling via Transcriptional and Posttranslational Regulation of β-Catenin in Lung Cancer.
Han F; Liu WB; Shi XY; Yang JT; Zhang X; Li ZM; Jiang X; Yin L; Li JJ; Huang CS; Cao J; Liu JY
EBioMedicine; 2018 May; 31():253-266. PubMed ID: 29739711
[TBL] [Abstract][Full Text] [Related]
5. Homeobox-A13 acts as a functional prognostic and diagnostic biomarker via regulating P53 and Wnt signaling pathways in lung cancer.
Wang Y; He B; Dong Y; He GJ; Qi XW; Li Y; Yang YF; Rao Y; Cen ZS; Han F; Ding J; Li JJ
Cancer Biomark; 2021; 31(3):239-254. PubMed ID: 33896818
[TBL] [Abstract][Full Text] [Related]
6. High expression of SRY-box transcription factor 30 associates with well differentiation, absent lymph node metastasis and predicts longer survival in nonsmall-cell lung cancer patients.
Liu C; Liu Y; Tian J; Zhang S; Li X; Zhai X; Feng Q
Medicine (Baltimore); 2020 May; 99(20):e20122. PubMed ID: 32443323
[TBL] [Abstract][Full Text] [Related]
7. SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer.
Han F; Liu WB; Li JJ; Zhang MQ; Yang JT; Zhang X; Hao XL; Yin L; Mao CY; Jiang X; Cao J; Liu JY
Endocr Relat Cancer; 2019 Mar; 26(3):303-319. PubMed ID: 30608899
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
9. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
10. LHX3 is an early stage and radiosensitivity prognostic biomarker in lung adenocarcinoma.
Lin X; Li Y; Wang J; Han F; Lu S; Wang Y; Luo W; Zhang M
Oncol Rep; 2017 Sep; 38(3):1482-1490. PubMed ID: 28731174
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
[TBL] [Abstract][Full Text] [Related]
12. Low expression of ITIH5 in adenocarcinoma of the lung is associated with unfavorable patients' outcome.
Dötsch MM; Kloten V; Schlensog M; Heide T; Braunschweig T; Veeck J; Petersen I; Knüchel R; Dahl E
Epigenetics; 2015; 10(10):903-12. PubMed ID: 26252352
[TBL] [Abstract][Full Text] [Related]
13. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
[TBL] [Abstract][Full Text] [Related]
14. CIRP promotes the progression of non-small cell lung cancer through activation of Wnt/β-catenin signaling via CTNNB1.
Liao Y; Feng J; Sun W; Wu C; Li J; Jing T; Liang Y; Qian Y; Liu W; Wang H
J Exp Clin Cancer Res; 2021 Aug; 40(1):275. PubMed ID: 34465343
[TBL] [Abstract][Full Text] [Related]
15. Expression of DR5 and c‑FLIP proteins as novel prognostic biomarkers for non‑small cell lung cancer patients treated with surgical resection and chemotherapy.
Zheng H; Zhang Y; Zhan Y; Liu S; Lu J; Wen Q; Fan S
Oncol Rep; 2019 Dec; 42(6):2363-2370. PubMed ID: 31638235
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.
Qu Y; Emoto K; Eguchi T; Aly RG; Zheng H; Chaft JE; Tan KS; Jones DR; Kris MG; Adusumilli PS; Travis WD
J Thorac Oncol; 2019 Mar; 14(3):482-493. PubMed ID: 30503889
[TBL] [Abstract][Full Text] [Related]
17. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
[TBL] [Abstract][Full Text] [Related]
18. WWC3 regulates the Wnt and Hippo pathways via Dishevelled proteins and large tumour suppressor 1, to suppress lung cancer invasion and metastasis.
Han Q; Lin X; Zhang X; Jiang G; Zhang Y; Miao Y; Rong X; Zheng X; Han Y; Han X; Wu J; Kremerskothen J; Wang E
J Pathol; 2017 Aug; 242(4):435-447. PubMed ID: 28543074
[TBL] [Abstract][Full Text] [Related]
19. Correlation of sex-determining region Y-box 30 with tumor characteristics and its prognostic value in breast cancer.
Peng H; Luo Y; Wu J; Yin W
J Clin Lab Anal; 2020 Jun; 34(6):e23232. PubMed ID: 32157740
[TBL] [Abstract][Full Text] [Related]
20. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Pajares MJ; Agorreta J; Larrayoz M; Vesin A; Ezponda T; Zudaire I; Torre W; Lozano MD; Brambilla E; Brambilla C; Wistuba II; Behrens C; Timsit JF; Pio R; Field JK; Montuenga LM
J Clin Oncol; 2012 Apr; 30(10):1129-36. PubMed ID: 22355056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
